Objectives: To assess the effects of daily prenatal multimicronutrient supplementation on birth weight (BW) and perinatal mortality. Design: Randomised, controlled, double masked trial. Setting: Urban Guinea-Bissau, West Africa. Subjects: A total of 2100 pregnant women (2277 weeks pregnant at entry) were recruited through antenatal clinics, of which 1670 (79.5%) completed the trial. BW was available for 1100 live born babies. Interventions: Identical-looking supplements containing one (MN-1) or two (MN-2) Recommended Dietary Allowances (RDA) of 15 micronutrients, or iron and folic acid (control). Results: Mean BW among 1100 live born infants was 30507498 g with 11.9% being low birth weight (LBW, BWo2500 g). Perinatal mortality was 82 per 1000 deliveries (N ¼ 1670), and neonatal mortality 45 per 1000 live births (N ¼ 1599). Mean BW in MN-1 (n ¼ 360) and MN-2 (n ¼ 374) groups were 53 [À19; 125] and 95 [24; 166] g higher than controls (n ¼ 366). Proportion of LBW was 13.6% in control, and 12.0 and 10.1% in the MN-1 and MN-2 groups, respectively (P ¼ 0.33). Among anaemic women (30%), MN-2 increased BW with 218 [81; 354] g compared to controls, with a decreased risk of LBW of 69 [27; 87]%. There were apparently no differences in perinatal mortality between groups. Conclusions: Prenatal micronutrient supplementation increased BW but did not reduce perinatal mortality in this study. Multimicronutrient supplementation with two RDA should be considered in future programmes to reduce the proportion of LBW.
Introduction
Low birth weight (LBW) is associated with increased risk of infant morbidity and mortality in developing countries (Ashworth, 1998; ACC/SCN, 2000b) . It has been estimated that infants weighing 2000-2500 and 2500-3000 g at birth are at four and two times higher risk of postneonatal mortality than those weighing 3000-3500 g, respectively. Through its impact on foetal growth and micronutrient stores, nutrition of the pregnant woman contributes to infant morbidity and mortality (Ceesay et al, 1997; Kramer, 2000; Tomkins, 2001; Christian, 2002) . Energy supplements may improve birth weight (bw) in some populations (Ceesay et al, 1997; Kramer, 2000) , but also micronutrient deficiencies are associated with poor pregnancy outcome. In developing countries, micronutrient intakes of pregnant women in general are considered insufficient to cover the increased requirements during pregnancy (Huffmann et al, 1998) .
UNICEF/WHO/UNU lately proposed a multimicronutrient prenatal supplement to replace the existing iron-folic acid supplement, which has been recommended for decades as a means of preventing maternal anaemia (Huffmann et al, 1998; UNICEF et al, 1999) . Prenatal multimicronutrient supplementation is considered a feasible public health strategy in areas with micronutrient deficiencies as it can be distributed to a high-risk group within existing logistics at a little extra cost, and can potentially benefit both mothers and their infants (de Onis et al, 1998; Shrimpton et al, 2002) . Still, the evidence for benefits of multimicronutrient supplementation on pregnancy outcome is sparse (Ramakrishnan et al, 1999; Mahomed, 2000; Osrin & de Costello, 2000; Scholl & Reilly, 2000; Allen & Gillespie, 2001) . Recent controlled trials in Mexico (Ramakrishnan et al, 2003) and Nepal (Christian et al, 2003) did not find any effects on bw of prenatal multimicronutrient supplementation in addition to the effect of iron and folic acid. However, doses of one recommended dietary allowance (RDA) may not be sufficient for pregnant women in populations with poor dietary quality and higher nutrient requirements and losses due to frequent infections.
We conducted a randomised, controlled double masked trial in which the effects on bw and perinatal mortality of prenatal multimicronutrient supplementation with one or two RDA of 15 micronutrients were compared with the conventional iron-folic acid supplement.
Subjects and methods

Study area and population
The study was carried out from January 2001 to October 2002 in a semiurban area in Bissau, the capital of GuineaBissau, West Africa, where demographic surveillance has been carried out by The Bandim Health Project for 25 y. The staple food is rice, usually consumed with fish. Red palm oil or a sauce prepared from the red palm fruit is frequently consumed with the rice. The climate is tropical with one rainy season from June to November and transmission of Plasmodium falciparum malaria occurs in all seasons. Prevalence of HIV-1 is low in Guinea-Bissau (2.2% among women o45 y) (Holmgren et al, 2003) . All women o37 weeks pregnant attending antenatal care at one of the two health centres in the study area were invited to participate in the study. Additionally, pregnant women who were identified by the Bandim Health Project's monthly surveillance and who had either not yet attended antenatal care service or attended other clinics/health centres, were visited in their homes and invited to participate. Women were recruited until late pregnancy since a major proportion of foetal weight gain occurs in the last two months of pregnancy, wherefore this period is expected to be a critical window for interventions aiming at increasing bw.
Ethics
The study was permitted by the Ministry of Health in Guinea-Bissau, and further approved by the Danish Central Medical Ethics Committee. After having received oral information about the study, women willing to participate gave their oral consent. Since illiteracy was common in the study population, we did not use written consent. However, written information was attached the antenatal cards of participating women. All women received an impregnated bed net at inclusion and were provided weekly anti-malarial prophylaxis with chloroquine phosphate (300 mg base) throughout pregnancy, in accordance with the national policy for pregnant women in Guinea-Bissau. Women with more than 10 parasites per 200 leucocytes at inclusion were also offered anti-malarial treatment with chloroquine. Women with severe anaemia (haemoglobin o70 g/l) received 60 mg iron per day in addition to their respective intervention.
Randomisation and intervention
The women enrolled in the study were individually randomised to one of three identical-looking micronutrient supplements (Table 1) . Supplements were prepared by Danish Pharmaceutical Industries Ltd. (Copenhagen, Denmark), which also provide the supplements for the UNICEF Supply Division in Copenhagen. Thus, formulation and appearance of tablets were identical to the supplements provided by UNICEF. One group received a daily multimicronutrient tablet containing one RDA (MN-1) of 15 micronutrients as recommended in the future prenatal supplement. Another group received multimicronutrients containing two RDA (MN-2), except for iron which was kept at one RDA. The control group received the conventional prenatal iron-folic acid supplement (control). Women were instructed to take one tablet daily, preferably together with breakfast. The manufacturer provided the tablets in containers with a colour code for each intervention group. This code was kept Micronutrient supplementation and pregnancy outcome in Guinea-Bissau P Kaestel et al secret from study participants, study personnel, and data analysts until data cleaning and preliminary data analysis had been carried out. Simple block randomisation with a block size of 150 was managed as follows: at entry, the project midwife randomly drew one piece of coloured paper corresponding to the colour code on the tablet containers from envelopes with initially 50 pieces of each of the three colours. In order to assess compliance, women were provided a container with 25 tablets. Remaining tablets were counted and replenished at fortnightly home visits throughout pregnancy. Compliance was expressed as the number of tablets consumed as a percentage of the number of days from enrolment to delivery. To make tablet distribution manageable with fortnightly visits and 6-800 women in the study at any time, coloured forms were used for the visits during pregnancy, the colour matching each subject's intervention group. However, the health workers who collected outcome data after delivery did not have any knowledge of intervention group of the women.
Maternal measurements
At enrolment, data on obstetric history, maternal age, ethnicity, occupation, and socio-economic status were obtained through interviews. Maternal height, body weight, arm circumference, and triceps skinfolds were measured. Haemoglobin concentration in capillary blood was measured in finger prick blood by use of the HemoCue system (Hemocue s , Sweden), which is based on the met-haemoglobin method. Anaemia, in this group of African women, was defined as haemoglobin r100 g/l (Johnson-Spear & Yip, 1994) . Malaria parasitaemia was determined from Giemsastained thin and thick blood slides. Parasites were identified through microscopic examination by a trained technician, and given as number of parasites per 200 leucocytes. Gestational age at inclusion was computed as the number of weeks from the first day of the last menstruation until date of enrolment, and length of gestation was computed similarly from last menstruation until delivery. Preterm delivery was defined as gestational duration less than 37 completed weeks. Maternal death was defined as death during pregnancy or within 42 days after termination of pregnancy, and maternal mortality as number of maternal deaths per 100.000 live births.
Infant measurements
Bw was preferably hospital records or body weight measured at the first home visit postpartum, within 3 days after delivery. Infants born at a maternity ward were weighed to the nearest 10 g on a standard beam balance shortly after birth. Further, all infants were visited at home as soon as possible after birth and weighed to the nearest 100 g on the same scale as women, carried by their mothers after reset of the scale (UNICEF electronic scale 890, Seca). When this visit was performed within 3 days of delivery it was used as BW when hospital data were not available. Low BW (LBW) was defined as BWo2500 g. Foetal loss before 28 completed weeks of gestation was defined as miscarriage. Perinatal mortality was defined as the number of stillborn (428 weeks gestation) plus live born who died within the first 7 days of life per 1000 deliveries. Neonatal mortality was defined as deaths within the first 28 days of life per 1000 live births. The source of information for mortality data was preferably the mother at a visit 2 months after delivery, alternatively the mother at a later occasion, or finally a relative or neighbour.
Statistical analyses
With 600 women in each treatment group, the study was powered to detect a reduction in perinatal mortality from the expected 9% in the control group to 5% or less in a treatment group, using 80% power and 95% confidence. With this sample size, we would be able to detect an increase in mean bw in an MN group by 80 g or more. All statistical analyses were performed with SPSS 11.0.1 (SPSS s Inc.). P-values o0.05 were considered significant. Data were analysed on an intention-to-treat basis. Covariance analysis (GLM) was used to test whether mean values of normally distributed continuous outcome variables differed between intervention groups. Logistic regression analysis was used to test whether binary outcomes differed between intervention groups.
First-born twins were included in the statistical analyses, while second-born twins were excluded. Season of birth was defined as birth in the early rainy (June-August), the late rainy (September-November), the early dry (DecemberFebruary), or the late dry season (March-May). Confounding and effect modification from malaria parasitaemia, anaemia, infant sex, and season of birth was assessed in multiple regression models. In order to identify effect modification of the supplementation, interaction terms between intervention and potential effect modifiers were included in models in which the main effects of both intervention and the potential effect modifier were also estimated. If P for interaction was o0.1, the analysis was stratified for different categories of the effect modifier, and the effects estimated separately. When the effects were estimated separately for anaemic and nonanaemic women, severely anaemic women (25 women with haemoglobin o70 g/l) were excluded from the analysis since they received additional iron.
Results
A total of 2100 pregnancies were enrolled from January 2001 to February 2002, and 8 weeks postpartum visits made from June 2001 to October 2002. The Bandim Health Project registered 2402 deliveries in the same period as the study participants gave birth, meaning that the study sample covered 87% of the total number of registered deliveries in the study area. The median (interquartile range) age of the women was 23 (20-28) . Half (49%) of the women were illiterate, and almost one-third (31%) never attended school. Malaria parasitaemia was common in all seasons with an overall prevalence of 46%. Prevalence of anaemia (haemoglobin r100 g/l) was 30.6%. Baseline characteristics for the three groups are presented in Table 2 . The randomisation resulted in comparable groups with respect to most baseline characteristics. However, the proportion of malaria parasitaemia was slightly higher among women in the control group compared to the MN groups.
The trial profile is shown in Figure 1 . Of the 2100 women, 430 (20%) were lost to follow-up mainly due to migration out of the study area. The loss rates were not different between intervention groups (P ¼ 0.09). Women who were lost during pregnancy entered the study 2 weeks earlier in pregnancy, were younger and had less education than women who completed the trial. There were no differences in baseline BMI, arm circumference or haemoglobin.
BW of live born babies measured within 3 days after birth was available for 1100 (66%) of the 1670 women who completed the trial (Table 3) . Among these, only 51 (4.6%) were measured at home that is 1 to 3 days after delivery. Those for whom, we did not obtain bw data were mainly stillbirths or home births. Mothers to infants with no bw available were slightly thinner, were of lower parity and had less education. There were no differences with respect to age and haemoglobin.
The mean7s.d. time of intervention from recruitment until delivery was 16.677.1 weeks, the number of tablets eaten was 81742, and compliance expressed as (number of tablets taken/number of days from inclusion to delivery) Â 100% was 76728%. Compliance was slightly higher in the control group, with 78, 76, and 74% in control, MN-1 and MN-2 groups, respectively, although the difference was not significant (P ¼ 0.12).
A total of 1670 women completed the trial until birth of which 71 (4.3%) were stillbirths. Total peri-and neonatal mortality rates were 81 per 1000 deliveries (135/1670), and 45 per 1000 live births (72/1599), respectively. Of the neonatal deaths 64 (89%) occurred within the perinatal period, while there were only eight deaths in the late neonatal period between 8 and 28 days after birth. Perinatal mortality was 58% higher among boys than among girls (OR ¼ 1.57 [1.08; 2.28]), and sex ratio among those who survived was 0.98 boys for each girl. There were 29 twin pairs (1.6%) and 43 (3.1%) caesarean sections. Mean BW was Micronutrient supplementation and pregnancy outcome in Guinea-Bissau P Kaestel et al o3000 g, respectively, and 24.2% preterm deliveries.
Effects of intervention
Continuous outcomes for the three different intervention groups based on intention-to-treat analyses are shown in Table 4 and binary outcomes in Table 5 . Three BW-derived outcomes were used: bw, proportion weighing o2500 g, and proportion weighing o3000 g. Further, peri-and neonatal mortality were evaluated. Malaria parasitaemia, anaemia, infant sex, and season were assessed for confounding and effect modification (Tables 4 and 5 ). (Table 4) . The supplementation shifted the whole distribution curve towards higher bws (Figure 2 ). From the lowest BWs to approximately 2800 g, the cumulative proportion of BWs were almost identical for MN-1 and control, followed by higher BWs for MN-1. bws of MN-2 were higher over the entire distribution, although the largest difference was seen between 2900 and 3500 g. The higher bw was translated into a lower proportion of LBW with 13.6, 12.0, and 10.1% in control, MN-1 and MN-2 groups, respectively, although the difference between groups Figure 1 Trial profile of 2100 pregnancies included in multimicronutrient trial. Micronutrient supplementation and pregnancy outcome in Guinea-Bissau P Kaestel et al did not reach significance ( Gestational age at entry did not appear to systematically influence the effect of supplementation on bw. There was no interaction between intervention group and gestational age at entry in four categories (P ¼ 0.39) and the effect estimates were not higher with decreasing gestational age at enrolment (data not shown).
BW and derived outcomes
There was no effect modification by season of birth, malaria, or infant sex for bw-associated outcomes but there was effect modification by maternal anaemia (P for interaction ¼ 0.06). The effect of MN-2 was highest among anaemic women with 218 [81; 354] g higher bw compared to anaemic controls (Table 6 ). Correspondingly, MN-2 reduced the proportion of LBW babies by 69% among the moderately anaemic women (OR ¼ 0.31 [0.13; 0.73]) (P for interaction ¼ 0.07). In fact, the proportion of LBW was not affected by MN-2 supplementation in nonanaemic women.
Peri-and neonatal mortality
There were no overall differences in either peri-or neonatal mortality between supplementation groups with 42, 50, and 44 deaths per 1000 live births in control, MN-1 and MN-2, respectively (Table 5 ). There was no effect modification by anaemia, malaria parasitaemia, infant sex, or season of birth.
Other outcomes
There were 29 miscarriages with 14, 13, and two in the control, MN-1 and MN-2 groups, respectively. This resulted in a significantly lower risk of miscarriage in the MN-2 group (OR ¼ 0.14 [0.031; 0.61]) but not in the MN-1 group Odds ratios (95% CI) using dummy variables for intervention group with control as reference, adjusted for malaria parasitaemia, anaemia, infant sex, and season of birth. d Proportion perinatal deaths (% of deliveries). (OR ¼ 0.93 [0.43; 2.00]), compared to control. Among these, two miscarriages in control and two in MN-1 group occurred within the first week of entry in the study. Excluding these from the analysis, did not make any major impact of the estimated reduced risk of miscarriage in the MN-2 group (OR ¼ 0.18 [0.039; 0.79]). Maternal mortality was 879 per 100.000 live births (14/ 1593) with 1346 (7/520), 760 (4/526), and 548 (3/547) deaths per 100.000 live births in control, MN-1, and MN-2 groups, respectively (P ¼ 0.35).
Discussion
We compared the conventional prenatal supplement with a multimicronutrient supplement, suggested by UNICEF, in a randomised, double-masked trial. Testing two different doses of micronutrients our results suggested a dose-response effect with 53 g increase in bw after administration of one RDA of the micronutrients and 95 g after two RDA. This is the first study evaluating the effects of prenatal multimicronutrient supplementation on pregnancy outcome in a population of predominantly HIV-negative African women.
The study covered 87% of the registered pregnancies in the study area and is considered representative of a poor semiurban population in West Africa. The main limitation of the study was the relatively high proportion of individuals for whom we did not obtain valid bw data. These women were primarily those who gave birth at home and those who had stillbirths. They differed with respect to gravidity and education; however, the proportion of women giving birth at home did not differ between groups and the estimates of the effects of our intervention are most likely valid.
Multimicronutrient supplementation had an impact on the whole distribution curve of bw, not only in the lower end. None of the supplements reduced the proportion of LBW babies significantly, although the MN-2 reduced the proportion by 31% from 13.6 to 10.1%. However, among anaemic women, the proportion of LBW was significantly reduced from 21% in the control group to 8% in the MN-2 group. It is plausible that anaemic women in particular will benefit from multimicronutrient supplementation as they are at high risk of multiple micronutrient deficiencies (ACC/ SCN, 2000a; Black, 2001; Shrimpton et al, 2002) .
Our data suggest that one RDA of multimicronutrients is not sufficient to considerably influence pregnancy outcomes in this African population of predominantly HIV negative women in a high malaria transmission area. This is supported by two recent studies in which prenatal multimicronutrient supplementation with one RDA did not increase bw (Christian et al, 2003; Ramakrishnan et al, 2003) . In Mexico, 873 women were given either 60 mg of iron or a multimicronutrient supplement including iron 6 days a week from before 13 weeks of gestation until delivery (Ramakrishnan et al, 2003) . Bw measured o72 h after birth did not differ between supplementation groups. In Nepal, prenatal multimicronutrient supplementation did not add any additional effect over iron-folic acid in reducing the risk of low bw (Christian et al, 2003) . Another recent study conducted in a population with 30% prevalence of HIV-1 in Zimbabwe suggested no effect in HIV-negative women of daily supplementation with one RDA of multimicronutrients (Friis et al, 2004) . In the same study there was an effect of micronutrient supplementation among HIV-positive women (100 (À3; 205) g), although the effect was not significantly different from the effect in HIV negative. We aimed to compare current with proposed future regimens of prenatal supplementation strategies in the developing world, and these regimens contain different amounts of iron (ie 60 and 30 mg, respectively). Concern has been raised about the effects of iron supplements to pregnant women, since excess iron can produce oxidative stress and may increase the risks of adverse pregnancy outcomes (Casanueva & Viteri, 2003) . Intestinal absorption of iron is enhanced by vitamin C, which is expected to compensate for the difference in iron content between our supplements. Anyway, it can be argued that our study cannot distinguish whether the observed effects are effects of multimicronutrients or rather effects of less iron. It is possible that the effect is partially mediated through the lower iron content in the MN supplements; however, since there was a tendency to a dose-response relationship between MN-1 and MN-2 supplements containing identical amounts of iron, we suggest that the effect was due to the multimicronutrients.
Gestational duration
The measurement of gestational duration was based on recall of last menstrual period, a measurement with high error in this population. The proportion of preterm deliveries was very high (24%) and this estimate is probably biased by recall, which is likely to result in an underestimated gestational duration and thus an overestimated proportion of preterm deliveries. Anyway, there are no reasons to believe that the bias is different between groups and the relative effects are probably valid. However, due to the noisy measurement of gestational age, we decided not to use it as an outcome measure but only to adjust for the effect of gestational age on bw. When gestational length was controlled for, it appeared that the effect of MN-2 but not of MN-1 was partially mediated through a longer gestation.
Mortality Surprisingly, the increased bw was not accompanied by a lower peri-or neonatal mortality in our study. The most recent review of the relation between bw and all-cause neonatal mortality (Ashworth, 1998 ) is based on observational studies that cannot distinguish whether effects on mortality are mediated through bw or are just concurrent. However, the public health impact of the increased bw should be further evaluated through assessment of postneonatal morbidity and mortality since an increase of the mean bw is expected to reduce postneonatal as well as neonatal mortality (Ashworth, 1998) . Further, it cannot be excluded that prenatal micronutrient supplementation could have effects on postneonatal mortality that are not mediated through bw.
Although the study was not designed to assess the impact of miscarriages as women were enrolled rather late in pregnancy, the risk of miscarriage was 86% lower in the MN-2 group compared to control. Mean gestational age at entry was not different between the intervention groups and there is no reason to doubt the validity of the comparison. This finding warrants further investigation.
Our study was not powered to assess maternal mortality rates though MN-1 and MN-2 apparently reduced the risk of maternal mortality substantially. In a larger observational study, maternal mortality in rural Guinea-Bissau has previously been estimated to 780 per 100 000 live births (Hoj et al, 2002) , which is lower than in our urban study. Maternal nutrition plays a role in maternal morbidity and mortality (Koblinsky, 1995; Tomkins, 2001) , although only few data exist on the effects of nutrition supplementation on maternal mortality. In a large study among more than 20 000 pregnant women in Nepal all-cause maternal mortality was reduced by 40% by weekly supplementation with vitamin A or b-carotene (West Jr et al, 1999) . Additional large intervention studies are needed to clarify whether multimicronutrient supplementation can prevent maternal deaths.
Women were included when they attended the health system for antenatal care, or as late as 3 weeks before expected delivery. Supplementation even in late pregnancy seemed to have a positive impact on bw, which is important from a public health point of view, since many women attend the antenatal services late in pregnancy. Energy deficiency in the third trimester is associated with poor foetal growth (Susser & Stein, 1994) and micronutrients associated with growth may also be limiting of growth in late gestation.
It is suggested that two rather than one RDA, which is promoted by UNICEF, should be considered in future prenatal multimicronutrient supplementation programs to add considerable benefits over iron-folic acid on bw. Particularly in settings where the first pregnancy contacts with the primary health care system occur rather late in pregnancy. It remains to be demonstrated whether there are any longer term effects of multimicronutrient supplementation on infant morbidity and mortality. and nurses for their contribution to the study. We thank
